Thesis icon

Thesis

Congenital myasthenic syndromes: characterisation of a new animal model, exploring potential novel therapies and assessing the outcome of COVID-19 infection

Abstract:

Background: Congenital Myasthenic Syndromes (CMS) are genetic disorders of the neuromuscular junction (NMJ) characterised by fatigable muscle weakness. Over 30 genes have been identified to cause CMS. Some lead to postsynaptic acetylcholine receptor (AChR) deficiency or altered receptor kinetic properties and in a group of patients with CMS, the mutations impair clustering of AChRs. Mutations in the delta subunit of AChR are infrequent but have been found in patie...

Expand abstract

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author

Contributors

Institution:
University of Oxford
Division:
MSD
Role:
Contributor
Role:
Contributor
Institution:
University of Oxford
Division:
MSD
Role:
Supervisor
ORCID:
0000-0001-7893-1348
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Supervisor
ORCID:
0000-0001-8600-6988
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Examiner
ORCID:
0000-0003-3653-834X


DOI:
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP